Globus Medical logo

Globus MedicalNYSE: GMED

Profile

Sector:

Healthcare

Country:

United States

IPO:

03 August 2012

Next earnings report:

05 November 2024

Last dividends:

N/A

Next dividends:

N/A
$10.29 B
0%vs. 3y high
93%vs. sector
253.30
0%vs. 3y high
96%vs. sector
-44%vs. 3y high
66%vs. sector
-46%vs. 3y high
58%vs. sector

Price

after hours | Fri, 01 Nov 2024 22:17:45 GMT
$75.99+$2.45(+3.33%)

Dividend

No data over the past 3 years
$629.69 M$603.93 M
$629.69 M$31.76 M

Analysts recommendations

Institutional Ownership

GMED Latest News

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud
accesswire.com03 November 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Globus Medical, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
accesswire.com02 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics
zacks.com31 October 2024 Sentiment: POSITIVE

Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud
accesswire.com27 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Globus Medical, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
accesswire.com26 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Globus Medical, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Should Contact The Schall Law Firm
accesswire.com20 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Globus Medical Inc For Possible Securities Fraud
accesswire.com19 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
globenewswire.com18 October 2024 Sentiment: POSITIVE

AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26.

Globus Medical Schedules Third Quarter Earnings Release and Conference Call
globenewswire.com15 October 2024 Sentiment: POSITIVE

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Globus Medical Inc For Possible Securities Fraud
accesswire.com15 October 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / October 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

What type of business is Globus Medical?

Globus Medical, Inc. is a technology company headquartered in Audubon, Pennsylvania, specializing in the development, manufacturing, and distribution of medical devices for the treatment and restoration of the musculoskeletal system of patients. It was founded in 2003. All products of Globus Medical can be divided into two groups: Musculoskeletal solutions - mainly consist of implants, biomaterials, devices, and surgical instruments used in spinal fusion procedures, orthopedic, and neurosurgical procedures (RISE, RISE-L, CALIBER, CALIBER -L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, XPand, QUARTEX, KINEX, AFFIRM, etc.). Supporting technologies - consist of surgical robotic solutions (ExcelsiusGPS, Surgimap).

What sector is Globus Medical in?

Globus Medical is in the Healthcare sector

What industry is Globus Medical in?

Globus Medical is in the Medical Devices industry

What country is Globus Medical from?

Globus Medical is headquartered in United States

When did Globus Medical go public?

Globus Medical initial public offering (IPO) was on 03 August 2012

What is Globus Medical website?

https://www.globusmedical.com

Is Globus Medical in the S&P 500?

No, Globus Medical is not included in the S&P 500 index

Is Globus Medical in the NASDAQ 100?

No, Globus Medical is not included in the NASDAQ 100 index

Is Globus Medical in the Dow Jones?

No, Globus Medical is not included in the Dow Jones index

When was Globus Medical the previous earnings report?

No data

When does Globus Medical earnings report?

The next expected earnings date for Globus Medical is 05 November 2024